Tariffs on Imported Medications Could Raise Costs for Americans, Experts Warn

New U.S. tariffs on prescription medications manufactured overseas could eventually impact what Americans pay for their prescriptions, according to experts at the Johns Hopkins Bloomberg School of Public Health. While the average patient may not feel the pinch immediately—especially those paying flat co-pays—rising costs absorbed by insurance companies could lead to higher premiums in the coming year.